Fig. 3From: Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritisAverage Weekly Doses of Etanercept Over the First Year of Therapy for All Indications* ETN, etanercept. *All indications refers to patients with a drug history representing juvenile idiopathic arthritis, psoriatic arthritis, or ankylosing spondylitis. Indications were inferred using an algorithm developed by IQVIA, which utilize a patient’s drug history [7, 8, 30]Back to article page